Abstract

Leishmania infantum, the etiological agent of canine leishmaniosis (CanL) in Europe, was responsible of the largest outbreak of human leishmaniosis in Spain. The parasite infects and survives within myeloid lineage cells, causing a potentially fatal disease if left untreated. The only treatment option relies on chemotherapy, although immunotherapy strategies are being considered as novel approaches to prevent progression of the disease. To this aim, a deeper characterization of the molecular mechanisms behind the immunopathogenesis of leishmaniosis is necessary. Thus, we evaluated, for the first time, the host immune response during L. infantum infection through transcriptome sequencing of the popliteal lymph nodes aspirates of dogs with CanL. Differential expression and weighted gene co-expression network analyses were performed, resulting in the identification of 5,461 differentially expressed genes (DEGs) and four key modules in sick dogs, compared to controls. As expected, defense response was the highest enriched biological process in the DEGs, with six genes related to immune response against pathogens (CHI3L1, SLPI, ACOD1, CCL5, MPO, BPI) included among the ten most expressed genes; and two of the key co-expression modules were associated with regulation of immune response, which also positively correlated with clinical stage and blood monocyte concentration. In particular, sick dogs displayed significant changes in the expression of Th1, Th2, Th17 and Tr1 cytokines (e. g. TNF-α, IFN-γ, IL-21, IL-17, IL-15), markers of T cell and NK cell exhaustion (e. g. LAG3, CD244, Blimp-1, JUN), and B cell, monocyte and macrophage disrupted functionality (e. g. CD40LG, MAPK4, IL-1R, NLRP3, BCMA). In addition, we found an overexpression of XBP1 and some other genes involved in endoplasmic reticulum stress and the IRE1 branch of the unfolded protein response, as well as one co-expression module associated with these processes, which could be induced by L. infantum to prevent host cell apoptosis and modulate inflammation-induced lymphangiogenesis at lymph nodes. Moreover, 21 lncRNAs were differentially expressed in sick dogs, and one key co-expression module was associated with chromatin organization, suggesting that epigenetic mechanisms could also contribute to dampening host immune response during natural L. infantum infection in the lymph nodes of dogs suffering from clinical leishmaniosis.

Highlights

  • Leishmaniosis is a zoonotic disease caused by Leishmania spp. and transmitted by blood-sucking phlebotomine sand flies

  • The main inclusion criteria were a positive serology result for L. infantum by immunofluorescence antibody assay (IFA) plus a positive cytology and a PCR result obtained from bone marrow or lymph node aspirates, as well as presenting with clinical signs or clinicopathological abnormalities associated with clinical stages II-III, according to LeishVet guidelines [32]

  • A total of 18 dogs met the inclusion criteria and were recruited for this study. Ten of these dogs were affected with canine leishmaniosis (CanL), and the other were healthy non-infected dogs which served as controls

Read more

Summary

Introduction

Leishmaniosis is a zoonotic disease caused by Leishmania spp. and transmitted by blood-sucking phlebotomine sand flies. L. infantum was identified as the causative agent of the largest outbreak of human leishmaniosis in Spain [4], which is the aetiological agent of canine leishmaniosis (CanL) in Europe This protozoan is an obligate intracellular parasite that lives within myeloid lineage cells. It is capable of reprogramming the host microenvironment to invade and persist within the mammalian host cells, causing a systemic, chronic, and potentially fatal disease if left untreated [5,6,7,8]. A deeper characterization and a better understanding of the complex molecular mechanisms behind the immunopathogenesis of L. infantum infection are necessary to successfully develop efficient immunomodulatory drugs and treatment strategies

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.